The role of screening expectations in modifying short–term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals

Patient Education and Counseling

Volumn 100, Issue 8, 2017, Pages 1572-1579

  Dunn, Charlotte E ^a   Edwards, Adrian ^a   Carter, Ben ^a,b   Field, John K ^c   Brain, Kate ^a   Lifford, Kate J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cue adaptive reasoning account; Lung cancer; Lung cancer screening; Screening expectations

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COPING BEHAVIOR; DIAGNOSTIC ACCURACY; EXPECTATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT ATTITUDE; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SUPPORT GROUP; UNITED KINGDOM; CLINICAL TRIAL; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; X-RAY COMPUTED TOMOGRAPHY;

AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PILOT PROJECTS; SURVEYS AND QUESTIONNAIRES; TOMOGRAPHY, X-RAY COMPUTED; UNITED KINGDOM;

EID: 85014359164     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2017.02.024     Document Type: Article

References (37)

1. World Cancer Research Fund International, Worldwide data, http://www.wcrf.org/int/cancer-facts-figures/worldwide-data, n.d. (Accessed October 10, 2015).
2. Cancer Research UK, Lung Cancer Statistics. n.d (Accessed 11 October 2015) http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer.
3. Cancer Research UK, Statistics and Outlook for Lung Cancer. 2015 (Accessed October 10, 2015) http://www.cancerresearchuk.org/about-cancer/type/lung-cancer/treatment/statistics-and-outlook-for-lung-cancer#general.
4. Ellis, P.M., Vandermeer, R., Delays in the diagnosis of lung cancer. J. Thorac. Dis. 3 (2011), 183–188, 10.3978/j.issn.2072-1439.2011.01.01.
5. Weedon-Fekjær, H., Romundstad, P.R., Vatten, L.J., Modern mammography screening and breast cancer mortality: population study. BMJ, 348, 2014, g3701, 10.1136/bmj.g3701.
6. Mortality colorectal screening reduction, (n.d.). http://www.extfiles.murciasalud.es/recursos/ficheros/39240-reducingMortalityColorectal-retocado.pdf (Accessed 10 October 2015).
7. Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., Fagerstrom, R.M., Gareen, I.F., Gatsonis, C., Marcus, P.M., Sicks, J.D., Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365 (2011), 395–409, 10.1056/NEJMoa1102873.
8. Matsumoto, M., Horikoshi, H., Moteki, T., Hatori, N., Tateno, Y., Iinuma, T., Matsumoto, T., Yamamoto, S., Baba, T., A pilot study with lung-cancer screening CT (LSCT) at the secondary screening for lung cancer detection. Nihon Igaku Hoshasen Gakkai Zasshi 55 (1995), 172–179.
9. Takemura, T., Sakai, E., Kusumoto, M., Itoji, E., Adachi, S., Kono, M., Utility of helical CT for the secondary mass screening of lung cancer. Nihon Igaku Hoshasen Gakkai Zasshi 52 (1992), 1322–1324.
10. Field, J.K., Duffy, S.W., Lung cancer screening: the way forward. Br. J. Cancer 99 (2008), 557–562, 10.1038/sj.bjc.6604509.
11. Field, J.K., Duffy, S.W., Baldwin, D.R., Whynes, D.K., Devaraj, A., Brain, K.E., Eisen, T., Gosney, J., Green, B.A., Holemans, J.A., Kavanagh, T., Kerr, K.M., Ledson, M., Lifford, K.J., McRonald, F.E., Nair, A., Page, R.D., Parmar, M.K.B., Rassl, D.M., Rintoul, R.C., Screaton, N.J., Wald, N.J., Weller, D., Williamson, P.R., Yadegarfar, G., Hansell, D.M., UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2016), 161–170, 10.1136/thoraxjnl-2015-207140.
12. Aberle, D.R., Berg, C.D., Black, W.C., Church, T.R., Fagerstrom, R.M., Galen, B., Gareen, I.F., Gatsonis, C., Goldin, J., Gohagan, J.K., Hillman, B., Jaffe, C., Kramer, B.S., Lynch, D., Marcus, P.M., Schnall, M., Sullivan, D.C., Sullivan, D., Zylak, C.J., The national lung screening trial: overview and study design 1. Radiology 258 (2011), 243–253, 10.1148/radiol.10091808.
13. Ru Zhao, Y., Xie, X., de Koning, H.J., Mali, W.P., Vliegenthart, R., Oudkerk, M., NELSON lung cancer screening study. Cancer Imaging 11 (2011), S79–S84, 10.1102/1470-7330.2011.9020 (Spec No).
14. McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A., Wardle, J., Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG. 111 (2004), 1437–1443, 10.1111/j. 1471-0528.2004.00279.x.
15. Watson, B.J., Henderson, J., Brett, C., The psychological impact of mammographic screening on women with a family history of breast cancer–a systematic review. Psychooncology 14 (2005), 939–948, 10.1002/pon.903.
16. Brain, K.E., Screening and prevention. French, K., Kaptein, A.A., Weinman, J., (eds.) Health Psychology, 2nd ed., 2010, Wiley, Blackwell Oxford, 220–232.
17. Brain, K., Lifford, K.J., Carter, B., Burke, O., McRonald, F., Devaraj, A., Hansell, D.M., Baldwon, D., DUffy, S.W., Field, J.K., Long-term psychosocial outcomes of low dose computed tomography screening: results of the UK Lung Cancer Screening (UKLS) randomised controlled trial. Thorax 71 (2016), 996–1005 http://dx.doi.org:10.1136/thoraxjnl-2016-208283.
18. Brain, K., Parsons, E., Bennett, P., Cannings-John, R., Hood, K., The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort. Psychooncology, 20, 2010, 10.1002/pon.1807 n/a–n/a.
19. Renner, B., Biased reasoning: adaptive responses to health risk feedback. Personal. Soc. Psychol. Bull. 30 (2004), 384–396, 10.1177/0146167203261296.
20. Baldwin, D.R., Duffy, S.W., Wald, N.J., Page, R., Hansell, D.M., Field, J.K., UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax 66 (2011), 308–313, 10.1136/thx.2010.152066.
21. Cassidy, A., Myles, J.P., van Tongeren, M., Page, R.D., Liloglou, T., Duffy, S.W., Field, J.K., The LLP risk model: an individual risk prediction model for lung cancer. Br. J. Cancer 98 (2007), 270–276, 10.1038/sj.bjc.6604158.
22. Field, J.K., Duffy, S.W., Baldwin, D.R., Brain, K.E., Devaraj, A., Eisen, T., Green, B.A., Holemans, J.A., Kavanagh, T., Kerr, K.M., Ledson, M., Lifford, K.J., McRonald, F.E., Nair, A., Page, R.D., Parmar, M.K.B., Rintoul, R.C., Screaton, N., Wald, N.J., Weller, D., Whynes, D.K., Williamson, P.R., Yadegarfar, G., Hansell, D.M., The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol. Assess, 20, 2016, 10.3310/hta20400.
23. McRonald, F.E., Yadegarfar, G., Baldwin, D.R., Devaraj, A., Brain, K.E., Eisen, T., Holemans, J.A., Ledson, M., Screaton, N., Rintoul, R.C., Hands, C.J., Lifford, K., Whynes, D., Kerr, K.M., Page, R., Parmar, M., Wald, N., Weller, D., Williamson, P.R., Myles, J., Hansell, D.M., Duffy, S.W., Field, J.K., The UK lung screen (UKLS): demographic profile of first 88 897 approaches provides recommendations for population screening. Cancer Prev. Res. 7 (2014), 362–371, 10.1158/1940-6207.CAPR-13-0206.
24. Bland, J.M., Altman, D.G., Statistics notes: multiple significance tests: the Bonferroni method. BMJ, 310, 1995, 170, 10.1136/bmj.310.6973.170.
25. Hilgart, J., Phelps, C., Bennett, P., Hood, K., Brain, K., Murray, A., I have always believed I was at high risk…” The role of expectation in emotional responses to the receipt of an average, moderate or high cancer genetic risk assessment result: a thematic analysis of free-text questionnaire comments. Fam. Cancer 9 (2010), 469–477, 10.1007/s10689-010-9324-y.
26. Shepperd, J.A., Novell, C.A., O'Neill, S.C., Docherty, S.L., Sanderson, S.C., McBride, C.M., Lipkus, I.M., Contemplating genetic feedback regarding lung cancer susceptibility. Ann. Behav. Med. 47 (2014), 395–403, 10.1007/s12160-013-9561-z.
27. Bennett, P., Wilkinson, C., Turner, J., Edwards, R.T., France, B., Griffith, G., Gray, J., Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment. Fam. Cancer 8 (2009), 159–165, 10.1007/s10689-008-9221-9.
28. Cullen, J., Short-term impact of cancer prevention and screening activities on quality of life. J. Clin. Oncol. 22 (2004), 943–952, 10.1200/JCO.2004.05.191.
29. van den Bergh, K.A.M., Essink-Bot, M.L., G.J.J.M, Borsboom, Th Scholten, E., Prokop, M., de Koning, H.J., van Klaveren, R.J., Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br. J. Cancer 102 (2010), 27–34, 10.1038/sj.bjc.6605459.
30. Gareen, I.F., Duan, F., Greco, E.M., Snyder, B.S., Boiselle, P.M., Park, E.R., Fryback, D., Gatsonis, C., Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 120 (2014), 3401–3409, 10.1002/cncr.28833.
31. Akobeng, A.K., Understanding randomised controlled trials. Arch. Dis. Child. 90 (2005), 840–844, 10.1136/adc.2004.058222.
32. Ali, N., Lifford, K.J., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D.R., Weller, D., Hansell, D.M., Duffy, S.W., Field, J.K., Brain, K., Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open, 5, 2015, e008254, 10.1136/bmjopen-2015-008254.
33. Studts, J.L., Ghate, S.R., Gill, J.L., Studts, C.R., Barnes, C.N., LaJoie, A.S., Andrykowski, M.A., LaRocca, R.V., Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol. Biomark. Prev. 15 (2006), 1825–1828, 10.1158/1055-9965 (EPI-06-0393).
34. van der Aalst, C.M., de Koning, H.J., Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial. Lung Cancer, 2016, 10.1016/j.lungcan.2016.02.001.
35. Brett, J., Bankhead, C., Henderson, B., Watson, E., Austoker, J., The psychological impact of mammographic screening. A systematic review. Psychooncology 14 (2005), 917–938, 10.1002/pon.904.
36. Kash, K.M., Holland, J.C., Halper, M.S., Miller, D.G., Psychological distress and surveillance behaviors of women with a family history of Breast cancer. J. Natl. Cancer Inst. 84 (1992), 24–30, 10.1093/jnci/84.1.24.
37. Lerman, C., Schwartz, M., Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Res. Treat. 28 (1993), 145–155, 10.1007/BF00666427.